Ibrumed 140 mg Capsule
$110.15
$54.39
Ibrumed 140 mg capsules are a targeted treatment option for adults diagnosed with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), particularly for those with specific genetic mutations that drive these conditions. This medication works by inhibiting the action of certain proteins involved in cancer cell proliferation, thereby slowing down the progression of these malignancies. Additionally, Ibrumed is indicated for the management of Waldenström's macroglobulinemia (WM), a rare form of non-Hodgkin lymphoma that affects the immune system. While Ibrumed is effective for these cancers, it’s essential for patients to be monitored for potential side effects, which may include low blood cell counts and increased risk of infections. Patients should inform their healthcare provider about any existing health conditions or medications, as these can influence treatment outcomes. As with any medication, adherence to prescribed dosages is critical for maximizing benefits and minimizing risks. Ibrumed represents a significant advancement in the therapeutic landscape for these hematological malignancies, offering hope to those affected by these challenging diseases. Always consult your healthcare professional for personalized advice and guidance regarding treatment with Ibrumed.
Quantity
Active Pharmaceutical Ingredient
Uses
• Ibrumed 140mg capsule is commonly used in adults diagnosed with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL). It helps manage the disease by targeting specific pathways involved in cancer cell survival. Patients often find it beneficial for controlling symptoms and slowing disease progression. This makes Ibrumed an important option in the treatment arsenal for these conditions.
• In cases where patients present with CLL or SLL featuring a 17p deletion, Ibrumed 140mg capsule is particularly effective. This genetic alteration can complicate treatment, but Ibrumed provides a targeted approach to manage these challenging cases. By inhibiting certain cellular processes, it aids in reducing the tumor burden. Thus, Ibrumed plays a crucial role in the therapeutic strategy for this subset of patients.
• Ibrumed 140mg capsule is also indicated for adults with Waldenström's macroglobulinemia (WM). This rare type of cancer can lead to significant health issues due to abnormal protein production. Ibrumed assists in managing the symptoms and complications associated with WM. Its mechanism of action helps patients achieve better disease control and improved quality of life.
• For both adults and children aged one year and older suffering from chronic graft versus host disease (cGVHD), Ibrumed 140mg capsule is a valuable treatment option after prior systemic therapies have failed. cGVHD can severely impact daily life, and Ibrumed works to alleviate symptoms and improve overall health outcomes. By targeting immune responses, it helps restore balance in the body. This makes Ibrumed an essential component in managing cGVHD effectively.
Benefits
Effective Treatment for CLL and SLL: Ibrumed 140 mg Capsule is proven to be effective in treating chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL), providing patients with an essential treatment option for these conditions.
Targets Specific Genetic Mutations: The Ibrutinib Capsule is particularly beneficial for adults with CLL/SLL who have specific genetic mutations, offering a tailored approach to treatment.
Management of Waldenström's Macroglobulinemia: Ibrutinib 140 mg Capsule is effective in treating Waldenström's macroglobulinemia (WM), a rare type of non-Hodgkin lymphoma, improving outcomes for patients with this condition.
Chronic Graft-Versus-Host Disease (cGVHD): Ibrumed 140 mg is also approved for treating cGVHD in adults and children aged 1 year and older when other treatments have failed, providing an option for patients facing complications after stem cell transplants.
By effectively managing symptoms and slowing disease progression, Ibrutinib Capsule can enhance the quality of life for patients living with CLL, SLL, WM, and cGVHD.
Side Effects
Anti-cancer Capsule Ibrumed can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Tiredness
• Low red blood cell count (anaemia)
• Bruising
• Diarrhea
• Muscle, bone, and joint pain
• Fever
Common Side Effects
• Muscle spasms
• Mouth sores (stomatitis)
• Bleeding
• Nausea
• Stomach pain
• Pneumonia
• Headache
How To Use
To take or give Ibrumed 140 mg Capsule, follow your doctor's instructions carefully. This Ibrumed Capsule is usually taken once a day with a full glass of water, either with or without food. Swallow the capsules whole; do not crush, chew, or break them. Keep to a schedule and try to take your doses at the same time each day. If you miss a dose, take it as soon as possible on the same day. Do not take extra doses to make up for a missed dose. Avoid grapefruit or grapefruit juice while you are taking Ibrutinib 140 mg Capsule, as it may interfere with the action of the medicine. Keep the medicine in a safe place away from children, and do not give it to anyone else, even if they have similar symptoms. If you have any questions or experience side effects, contact your doctor for advice.
Safety Advice
• Alcohol: It is not known whether it is safe to drink alcohol with Ibrumed 140 mg. Please consult your doctor.
• Kidney: Ibrumed 140 mg Capsule should be used with caution in patients with kidney disease. The dose of Ibrutinib 140 mg Capsule may need to be adjusted. Please consult your doctor.
• Breastfeeding: Ibrutinib Capsule should be used with caution during breast-feeding. Breastfeeding should be continued until the mother's treatment is complete and the drug has been eliminated from her body.
• Liver: Anti-cancer Capsule Ibrumed should be used with caution in patients with liver disease. The dose of Ibrumed 140 mg may need to be adjusted. Please consult your doctor.
• Pregnancy: Ibrumed Capsule is not safe to use during pregnancy, as there is clear evidence of a risk to the developing baby. However, the doctor may rarely prescribe it in certain life-threatening situations where the benefits outweigh the potential risks. Please consult your doctor.
• Driving: Ibrutinib 140 mg Capsule can cause side effects that may affect your ability to drive a car.